Meta-analysis of 16 studies (1551 patients) of giant cell tumour surgery: perioperative denosumab was associated with higher local recurrence (OR 1.82), mainly with both pre- and postoperative use; preoperative-only use was not.
Meta-analysisn = 1,551
Daher et al. The Association Between Perioperative Denosumab and Local Recurrence After Surgical Management of Giant Cell Tumors: A Meta-Analysis